{
  "680926":{
    
  },
  "682790":{
    "Figure_8.tif":{
      "A":{
        "descriptions":[
          "(A) Sequences of RNAIp and RNAIIp probes. ",
          "(A), were used to analyze exchange of RNA polymerase from DR region to RNAIp and RNAIIp. "
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          "(B) Purified RNA polymerase "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2035,
            "y2":1366
          }
        ]
      },
      "RP":{
        "descriptions":[
          "(RP) was added to 32P-labeled-DR probe (Fig. 7A). Unlabeled RNAIIp and RNAIp probes, which contained sequences shown in "
        ],
        "rois":[
          
        ]
      },
      "C":{
        "descriptions":[
          "(C) DNA-protein complexes that contained a biotinylated-DR probe (Bio-DR) and RNA polymerase (Bio-DR/RP) were captured using streptavidin-coated magnetic beads. After unbound RNA polymerase had been removed, 32P-labeled RNAIIp and RNAIp probes were added to RNA polymerase-DR complex to analyze exchange of RNA polymerase from repeats to RNAIp and RNAIIp. Probe 167 was used as a negative control."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2035,
            "y2":1366
          }
        ]
      }
    }
  },
  "687629":{
    
  },
  "689579":{
    
  },
  "692822":{
    "Figure_1.tif":{
      "A":{
        "descriptions":[
          "(A) The tool contains three logical levels: the interface level, explanation level and calculation level. The interface level is an editor to build biological models and integrate necessary information and parameters. The explanation level is a complier to understand the user???s biological model and translate it into the mathematical model. The calculation level is a computational element to calculate the model and return the results. "
        ],
        "rois":[
          {
            "x":18,
            "y":18,
            "x2":1697,
            "y2":4145
          },
          {
            "x":1894,
            "y":210,
            "x2":4849,
            "y2":3189
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) The interface of building the model and setting parameters. With a user-friendly interface, the tool provides an instant visual bio-model building environment. For user convenience, GeneCircuits chose standard icons to present biological elements. For example, a gene icon is represented by a set of standard sub-symbols, including two regulatory domains (white square), one mRNA (hollow parallelogram) and one corresponding protein (solid red rounded quadrilateral). Users can define the various roles of each element in the system. Based on the Petri net representation, each reaction has a horizontal line, which is a representation of the reaction. By double-clicking this horizontal line, users can set up parameters of the reaction. "
        ],
        "rois":[
          {
            "x":1894,
            "y":210,
            "x2":4849,
            "y2":3189
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) The user interface for setting parameters."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "694253":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "EGFP+ cells from male donors were injected into liver-injured female mice. (A)"
        ],
        "rois":[
          {
            "x":2121,
            "y":3997,
            "x2":2940,
            "y2":4902
          },
          {
            "x":1822,
            "y":2921,
            "x2":2652,
            "y2":3750
          },
          {
            "x":15,
            "y":47,
            "x2":604,
            "y2":871
          }
        ]
      },
      "B":{
        "descriptions":[
          " After transplantation of stem cells, the EGFP fluorescence in the lung, liver, spleen and kidney was examined using bio- imaging system. A luminescent image from red (least intense) to yellow (most intense) represents the spatial distribution of the detected photons emitted from EGFP+ cells within the organs. The EGFP signal was not detected in the control mice. (B)"
        ],
        "rois":[
          {
            "x":25,
            "y":1843,
            "x2":3741,
            "y2":2805
          },
          {
            "x":2152,
            "y":16,
            "x2":3901,
            "y2":1785
          },
          {
            "x":654,
            "y":15,
            "x2":2106,
            "y2":871
          },
          {
            "x":398,
            "y":925,
            "x2":2109,
            "y2":1920
          }
        ]
      },
      "P":{
        "descriptions":[
          " mRNA levels of CXCR4 on MSCs and HSCs. P"
        ],
        "rois":[
          {
            "x":34,
            "y":2816,
            "x2":2031,
            "y2":4962
          }
        ]
      },
      "C":{
        "descriptions":[
          " Average radiance was quantified in the liver after stem cells transplantation. (C)"
        ],
        "rois":[
          {
            "x":2709,
            "y":2804,
            "x2":3749,
            "y2":3808
          },
          {
            "x":25,
            "y":1843,
            "x2":3741,
            "y2":2805
          },
          {
            "x":398,
            "y":925,
            "x2":2109,
            "y2":1920
          }
        ]
      },
      "H":{
        "descriptions":[
          " PCR-based detection of donor-derived cells in the livers of different recipients. (D and E) Liver sections were stained with DAPI, and the distribution of EGFP+ cells in the portal lobe was quantified in the different groups at 4 weeks. White arrows show the stem cells in the sinusoids (i, MSCs group; ii, HSCs group; and iii, MSCs+HSCs group). (F and G) FACS analyses of CXCR4 expression on MSCs and HSCs. (H)"
        ],
        "rois":[
          {
            "x":3015,
            "y":3999,
            "x2":3918,
            "y2":4896
          },
          {
            "x":398,
            "y":925,
            "x2":2109,
            "y2":1920
          }
        ]
      }
    }
  },
  "697108":{
    
  },
  "697113":{
    "Figure_3.tif":{
      "E":{
        "descriptions":[
          "(E) Concentration-response curve between bio-MTX and AlBj obtained from SPR analysis. Rmax???=???66. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2059,
            "y2":1322
          }
        ]
      },
      "RU":{
        "descriptions":[
          ". RU: resonance unit. 1 RU???=???1 pg/mm2."
        ],
        "rois":[
          {
            "x":0,
            "y":1323,
            "x2":2059,
            "y2":2126
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) Scatchard-plot analysis of AlBj binding to MTX. "
        ],
        "rois":[
          {
            "x":0,
            "y":1323,
            "x2":2059,
            "y2":2126
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Full length map of HMGB1 and truncated recombinant versions of the protein engineered in E. coli. The displayed sequence of the MTX-binding T7 phage particle (K86-V175) includes the Box B domain (K89-Y161), TLR4-binding domain (F88-E107) and part of the RAGE-binding domain (K149-V175). "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2059,
            "y2":1322
          }
        ]
      },
      "G":{
        "descriptions":[
          "(G) Hill-plot analysis of AlBj binding. Hill coefficients n???=???1.1"
        ],
        "rois":[
          {
            "x":0,
            "y":1323,
            "x2":2059,
            "y2":2126
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) SDS-PAGE of AlBj, Al and Bj proteins after purification by affinity chromatography. The bands were stained with CBB. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2059,
            "y2":1322
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C, D) Representative SPR sensorgram with a global fitting curve between bio-MTX and Al ",
          "(C) or Bj "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2059,
            "y2":1322
          }
        ]
      },
      "D":{
        "descriptions":[
          "(C, D) Representative SPR sensorgram with a global fitting curve between bio-MTX and Al ",
          "(D). Solutions containing various concentrations of Al (0.31???5 ??M) or Bj protein (0.16???2.5 ??M) were injected over the immobilized MTX-biotin on a SA sensor chip for 120 s and then dissociation was monitored for a further 120 s at a flow rate of 30 ??l/min. Response curves were generated by subtraction of the background signals generated simultaneously on the control flow cell (bio-MTX-non-immobilized cell) and the injection of vehicle (0 ??M analyte). "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2059,
            "y2":1322
          }
        ]
      }
    }
  },
  "698423":{
    
  },
  "700228":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "(A) Dendritic cells were exposed to the indicated concentrations of NPs for 24 hrs and assessed for viability using 7-AAD and apoptosis by Po-Pro staining. As negative and positive controls, DCs were left untouched (mock) or treated with 1 ??g/ml Fas ligand (FAS), respectively. Bar graph data are plotted as mean ??SD. "
        ],
        "rois":[
          {
            "x":9,
            "y":9,
            "x2":2050,
            "y2":1289
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Dendritic cells were exposed to the indicated concentrations of NPs for 24 hours and assessed for phenotypic expression of human DC markers, as indicated, by flow cytometric analysis. "
        ],
        "rois":[
          
        ]
      },
      "C":{
        "descriptions":[
          "(C) Supernatants from DCs stimulated with 1 ??M of either NPs were examined for soluble cytokines by Bio-Plex assay. Each dot on the scatter plot represents the signal for an individual donor; Data are mean+/???SD, n???=???10. A paired t-test was performed: **p2 or CeO2 group; ????p"
        ],
        "rois":[
          {
            "x":9,
            "y":9,
            "x2":2050,
            "y2":1289
          }
        ]
      }
    }
  },
  "700233":{
    
  },
  "7007153":{
    
  },
  "70102":{
    
  },
  "70104":{
    
  },
  "706268":{
    
  },
  "706521":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "(A) HCMV transcriptome 5 days post infection. "
        ],
        "rois":[
          {
            "x":31,
            "y":17,
            "x2":4069,
            "y2":981
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) HCMV transcriptome 18 days post infection. Transcript analysis was performed using CLC Bio Genomics Workbench software. Peaks were calculated and determined based on 4 independent experiments and using a minimum of 20 read cut off and pValue of Inset: RT-PCR evaluation of identified ORFs during lytic or latent infection. Negative controls for latent infection: IE2, UL13 and US21. CycloA???=???cyclophillin A. "
        ],
        "rois":[
          {
            "x":15,
            "y":1014,
            "x2":4088,
            "y2":4485
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) HCMV transcriptome upon reactivation of latently infected CD14 (+) monocytes with treatment of IL-6 and culturing cells on a surface that allows for cell attachment."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "71279":{
    
  },
  "71365":{
    
  },
  "71373":{
    
  },
  "71624":{
    
  },
  "717060":{
    
  },
  "718825":{
    "Figure_5.tif":{
      "E":{
        "descriptions":[
          "(E) Relative fold induction of TOP-flash, IFNB1, ISG56"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2265,
            "y2":2710
          }
        ]
      },
      "NF":{
        "descriptions":[
          ", NF-??B and EF1??-driven reporter activity in HEK 293T cells subjected to GSK3 inhibition with BIO (5 ??M), TCF/LEF interaction inhibition with PNU74654 (6 ??M) or both inhibitors prior to SeV infection for 16 hours."
        ],
        "rois":[
          
        ]
      },
      "A":{
        "descriptions":[
          "(A) and fold induction of CTNNB1-TCF/LEF dependent reporter activity TOP-flash "
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          "(B) in HEK 293T cells transduced with lentivirus-expressing shRNA NT (control) or shRNA 45 targeting CTNNB1 for four days and subjected to GSK3 inhibition with BIO (5 ??M) or BIO-acetoxime (10 ??M) and SeV infection for 16 hours. "
        ],
        "rois":[
          
        ]
      },
      "C":{
        "descriptions":[
          "(C) Immunoblot analysis of autophosphorylated GSK3??/?? at Tyr279/216, dephosphorylated active CTNNB1 at Ser37/Thr41 and IFIT1 in HEK 293T cells treated with GSK3 inhibitors BIO (5 ??M) or BIO-acetoxime (10 ??M) and infected with SeV for 16 hours. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2265,
            "y2":2710
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) Immunoblot analysis of dephosphorylated active CTNNB1 at Ser37/Thr41, IFIT1 and phosphorylated NFKBIA (I??B??) at Ser32 in SeV-infected HEK 293T cells treated as described in (A???B) and treated with BIO (5 ??M) or BIO-acetoxime (10 ??M). "
        ],
        "rois":[
          
        ]
      }
    }
  },
  "718826":{
    "Figure_6.tif":{
      "E":{
        "descriptions":[
          "(E) Immunoblot analysis of dephosphorylated active CTNNB1 at Ser37/Thr41, IFIT1 and HCV NS3 protease in primary human hepatocytes either transduced with lentivirus-expressing shRNA 45 targeting CTNNB1 for four days and/or subjected to GSK3 inhibition with BIO (5 ??M) and infected with Hepatitis C virus (HCV) strain JFH1 for 48 hours. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2283,
            "y2":1388
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) Huh7 cells transduced with shRNAs NT, WNT2B 76, WNT2B 77, WNT9B 69, WNT9B 70, WLS 58, WLS 99, CTNNB1 45 or YB1 48 (positive control) were infected with HCV J6/JFH-1(p7-Rluc2A) reporter virus. Following 96 hours of infection, Rluc was measure to assess HCV viral replication and results are represented as relative viral infection with shRNA NT treated cells arbitrarily set to 1. P values"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2283,
            "y2":1388
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) and TNF "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2283,
            "y2":1388
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) mRNA levels in NHBE cells transduced with lentivirus-expressing shRNA 77 targeting WNT2B, shRNA 69 targeting WNT9B, shRNA 58 targeting WLS, shRNA 45 targeting CTNNB1 and NT shRNA in control cells for four days and infected with SeV for 16 hours. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2283,
            "y2":1388
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Fold induction of IFNB1, IFIT1 and TNF mRNA levels in human monocyte-derived macrophages subjected to GSK3 inhibition with BIO (5 ??M) and SeV infection for 4 hours. qRT-PCR determination represents the average mRNA RQ normalized versus ACTIN and HPRT1 mRNA. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2283,
            "y2":1388
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) Fold induction of IFIT1 mRNA in primary human hepatocytes transduced with lentivirus-expressing shRNA NT or shRNA 45 targeting CTNNB1 for four days and subjected to GSK3 inhibition with BIO (5 ??M) and SeV infection for 5 hours. qRT-PCR determination represents the average mRNA RQ normalized versus ACTIN and HPRT1 mRNA. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2283,
            "y2":1388
          }
        ]
      }
    }
  },
  "72812":{
    
  },
  "728124":{
    "Figure_5.tif":{
      "a":{
        "descriptions":[
          "(a) Microscopic images of ES cells on day 4 of induction. ES cells were cultured with lignin (50 ??g/mL) and various concentrations of 6-BIO (1, 2 and 4 ??M). "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2058,
            "y2":523
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) Gene expression analysis by real-time PCR. Changes in the expressions of differentiation marker genes associated with the addition of lignin and 6-BIO were analyzed on day 4 of culture. The expression level of each marker gene was normalized to control. Scale bar: a???=???200 ??m Data are expressed as the mean ?? SD of the three experiments. *P"
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          
        ],
        "rois":[
          {
            "x":0,
            "y":524,
            "x2":2058,
            "y2":2300
          }
        ]
      }
    }
  },
  "728127":{
    
  },
  "729226":{
    
  },
  "730795":{
    "Figure_4.tif":{
      "A":{
        "descriptions":[
          "(A) STAT1 expression was detected by Western blotting. Band intensities were quantified using Quantity One 4.4.0 software (Bio-Rad) and then normalized to the amount of GAPDH in each sample. All samples were compared with the signal detected in Non-target shRNA transduced cells. The data are representative of three independent experiments. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3403,
            "y2":2275
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) NBT reduction assay was performed as described. The percentage of NBT-positive cells was calculated by counting at least 200 cells under a light microscope. Data presented are the mean ?? SD of three independent experiments. *** P"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3403,
            "y2":2275
          }
        ]
      }
    }
  },
  "73892":{
    
  },
  "73893":{
    
  },
  "73894":{
    
  },
  "740321":{
    "Figure_6.tif":{
      "4":{
        "descriptions":[
          "(4), SP Sephadex C-25 "
        ],
        "rois":[
          
        ]
      },
      "5":{
        "descriptions":[
          "(5), Sephacryl S-200 beads "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2871,
            "y2":1901
          }
        ]
      },
      "6":{
        "descriptions":[
          "(6), or DEAE-Sephadex "
        ],
        "rois":[
          
        ]
      },
      "1":{
        "descriptions":[
          "(1), Dynabeads M-280 Streptavidin "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2871,
            "y2":1901
          }
        ]
      },
      "2":{
        "descriptions":[
          "(2), Biorex 70 Resin "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2871,
            "y2":1901
          }
        ]
      },
      "7":{
        "descriptions":[
          "(7) for 30 minutes at room temperature. The sample was washed 4 times with water and then particles were tested in plaque assays to determine how much virus was bound by the particles. B) NT53 or HTP was incubated with purified RNA at 1.0E+7 genomic copies for 30 minutes at room temperature. Following water washes, the samples were resuspended in water and treated with 380 Units/ml of RNase A. Samples with no RNase A treatment were processed in parallel. The viral RNA was extracted from isolated particles and quantitated by qRT-PCR (black bars). Samples without NT53 were processed in parallel (gray bars). C) NT53 and HTP beads were incubated with viral supernatants containing RVFV at 1.7E+8 pfu/ml for 30 minutes at room temperature. Samples were then inactivated by incubation at 57??C for one hour or incubating in the presence of 1% NP-40 at room temperature for 1 hour. A ???no bead??? control processed in parallel was included for each condition. Viral RNA was extracted from the particles and quantitated by qRT-PCR."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2871,
            "y2":1901
          }
        ]
      },
      "3":{
        "descriptions":[
          "(3), Bio-gel HTP Hydroxyapatite "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2871,
            "y2":1901
          }
        ]
      }
    }
  },
  "741365":{
    
  },
  "742603":{
    "Figure_4.tif":{
      "A":{
        "descriptions":[
          "A). Increased IL-6 producing JAWSII cells and elevated IL-6 levels in lymphocytes culture media upon mMSLN-VLP treatment. JAWSII cells were stimulated with MSLN-VLP (5 ??g/ml) for 12 h and intracellular IL-6 staining was performed. Lymphocytes were prepared from spleen of na??ve B6 mice. After incubation with MSLN-VLP for 24 h, supernatant was collected to determine IL-6 concentrations by Bio-Plex"
        ],
        "rois":[
          {
            "x":13,
            "y":13,
            "x2":2723,
            "y2":2111
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B). Partial rescue of suppressive effect of mMSLN-VLP stimulation on foxp3+ Treg cells by IL-6 neutralization. MSLN-VLP with or without IL-6 neutralizing Ab or isotype control Ab were added to lymphocytes culture for 3 days. The foxp3+ cells were stained by using foxp3 intracellular staining kit. Data was acquired for flow cytometry analysis gated on CD3+ and CD4+ T cells. Shown were representative data from three to five independent experiments. (Statistically significances are shown, ** indicate p"
        ],
        "rois":[
          
        ]
      }
    }
  },
  "743190":{
    "Figure_1.tif":{
      "N":{
        "descriptions":[
          "(N) assayed at each timepoint. Urine samples of different genotypes but from the same month were tested in all possible cases on the same ELISA plate. There were no statistically significant differences by ANOVA (In-Stat3) for all groups and all time points with the exception of some 16 week and 28 week time points, which fit a pattern suggestive of plate-plate variation rather than progressive glomerulosclerosis. For instance, the 16 week KO is significantly lower than the KO at 24 weeks (by ANOVA with Tukey-Kramer post test 0.05 for all combinations of 24 week KO versus DH versus ff). It is simply that all 16 week values were atypically low, due either to aberrancy in the ELISA plate or to an unknown confounder at the time of that urine collection. Similarly, the 28 week DH and ff groups are significantly different than the KO 24 week time point (pMyh9 KO mice is not significantly different from control littermates within the same month, and podocyte-specific Myh9 KO mice do not show progressive albuminuria with aging from 8 weeks to 28 weeks."
        ],
        "rois":[
          {
            "x":9,
            "y":1908,
            "x2":1135,
            "y2":2080
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) Urine from all mice was screened for albuminuria every 4 weeks by SDS-PAGE with Coomassie stain. Shown here is one of 2 gels from 28 week old mice. M???=???marker (Precision-Plus Dual Color, Bio-Rad), BSA???=???bovine serum albumin diluted from 1 mg/mL stock to the indicated amounts per lane (ug). Sample lanes contain 10 uL of mouse urine of the indicated genotype: "
        ],
        "rois":[
          
        ]
      },
      "FF":{
        "descriptions":[
          "(FF)???=???cre???; Myh9flox/flox. As an internal control, we observed low molecular weight (tubular) proteinuria from each urine sample lane but no significant albuminuria at this time or at any other time point. These urine samples are not normalized for concentration but provide an initial screen for albuminuria. "
        ],
        "rois":[
          {
            "x":17,
            "y":9,
            "x2":1136,
            "y2":779
          }
        ]
      },
      "DH":{
        "descriptions":[
          "(DH)???=???Podocin::Cre/+; Myh9flox/+, "
        ],
        "rois":[
          {
            "x":9,
            "y":1908,
            "x2":1135,
            "y2":2080
          },
          {
            "x":18,
            "y":915,
            "x2":1254,
            "y2":1883
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Quantification of albuminuria by urine albumin::creatinine ratio (ACR). Albuminuria was measured by plate ELISA (albuwell-M kit, Exocell/Glycadia) and creatinine was measured by endpoint-assay (Teco Diagnostics). For both assays, every plate included 8 standards and only plates for which the standards fit a straight line (r2>0.98) were accepted for analysis. All results from mouse urine that fell outside the linear range were repeated using additional urine dilutions. Legend???=???mouse genotypes as described above. Y-axis???=???urine to creatinine ratio (in ug/mg) +/??? standard deviation. X-axis???=???urine collections every four weeks from week 8 onwards. The table below the X axis shows the number of animals "
        ],
        "rois":[
          
        ]
      },
      "KO":{
        "descriptions":[
          "(KO)???=???Podocin::Cre/+; Myh9flox/flox, "
        ],
        "rois":[
          {
            "x":9,
            "y":1908,
            "x2":1135,
            "y2":2080
          }
        ]
      }
    }
  },
  "743195":{
    "Figure_5.tif":{
      "A":{
        "descriptions":[
          "(A) SDS-PAGE with Coomassie stain of urine 4 days after injection to screen for albuminuria. M???=???marker (Precision Plus Dual Color, Bio-Rad); BSA???=???bovine serum albumin in ug/lane. Sample lanes of the indicated genotype contain 2.5 microliters of urine in sample buffer. "
        ],
        "rois":[
          {
            "x":11,
            "y":1109,
            "x2":1752,
            "y2":2217
          }
        ]
      },
      "KO":{
        "descriptions":[
          "(KO)???=???Podocin::Cre/+; Myh9flox/flox and "
        ],
        "rois":[
          {
            "x":9,
            "y":8,
            "x2":1513,
            "y2":1008
          }
        ]
      },
      "FF":{
        "descriptions":[
          "(FF)???=???cre???; Myh9flox/flox. "
        ],
        "rois":[
          {
            "x":84,
            "y":2257,
            "x2":1517,
            "y2":2531
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Quantification of albuminuria normalized to urine concentration. Y axis is the ACR (ratio of albuminuria to urine creatinine), similar to Figures 1 and 3. Numbers of animals for each timepoint and each genotype are indicated below the abscissa. Data were analyzed by unpaired T-test with Welch correction. On one hand, as intended, KO mice had significantly more albuminuria after receiving NTS: (*) ACR on day1 after NTS was 239+/???44 ug/mg versus day 0 ACR of 0.2 ug/mg+/???0.0007, p???=???0.01, and albuminuria after NTS injection persisted through day 14. Similarly (**), the ACR on day1 after NTS was 239+/???44 ug/mg versus 0.4+/???0.3 ug/mg on day 1 after control sheep IgG, p???=???.012). However, (??????) for each day after injection with NTS, there is no difference in the magnitude of albuminuria between KO and control mice: day 1 p???=???0.58; day 2 p???=???0.31; day 3 p???=???0.20; day 4 p???=???0.396; day 7 p???=???0.37. At day 14, there is a trend towards a difference between KO and control mice injected with NTS, p???=???0.06, but in addition to the low N, this late timepoint is confounded by the contribution of an Fc dependent response from the immune system."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "743716":{
    "Figure_3.tif":{
      "A":{
        "descriptions":[
          "A) Immunostaining of N-MVECs with anti-desmoglein-2 and anti-integrin-beta8 antibodies (nuclei stained with DAPI) in a single N-MVEC (upper row) and in a group of N-MVECs (lower row). The results shown are indicative of experiments performed on 3 different N-MVEC cell lines. Original magnification: ??60 (Bio-Rad MRC 1024 ES Confocal Laser Scanning Microscope)"
        ],
        "rois":[
          {
            "x":7,
            "y":7,
            "x2":1801,
            "y2":853
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B) Co-immunoprecipitation of integrin-beta8 and desmoglein-2. The lanes 1, 2 and 3 of each blot represent 1) input: total lysate, 2) protein A beads alone, 3) protein A beads + anti-Desmoglein-2 or anti-Integrin-beta8 antibody, respectively. Left side: immuno-blotting with anti-desmoglein-2 (upper part) and anti-integrin-beta8 (lower part) antibodies of the immuno-precipitates obtained with the same antibodies. Right side: immuno-blotting with anti-integrin-beta8 antibodies of the immuno-precipitate obtained with anti-desmoglein-2 antibodies (upper part), and immuno-blotting with anti-desmoglein-2 antibodies of the immuno-precipitate obtained with anti-integrin-beta8 antibodies (lower part). Numbers on the left indicate molecular weight (kDa) of the revealed bands"
        ],
        "rois":[
          {
            "x":7,
            "y":860,
            "x2":1801,
            "y2":1338
          }
        ]
      },
      "IP":{
        "descriptions":[
          ". IP: immuno-precipitate"
        ],
        "rois":[
          {
            "x":7,
            "y":860,
            "x2":1801,
            "y2":1338
          }
        ]
      },
      "IB":{
        "descriptions":[
          "; IB: immuno-blotting. The data shown represent a typical experiment out of three experiments on each N-MVEC line, all of which gave similar results."
        ],
        "rois":[
          {
            "x":7,
            "y":860,
            "x2":1801,
            "y2":1338
          }
        ]
      }
    }
  },
  "743721":{
    "Figure_6.tif":{
      "A":{
        "descriptions":[
          ". Panel A: RT-PCR of the relevant transcripts in SSc-MVECs, relative to N-MVECs. Data are expressed as log2 of fold change. Negative values indicate decreased expression levels"
        ],
        "rois":[
          {
            "x":7,
            "y":8,
            "x2":1493,
            "y2":611
          }
        ]
      },
      "B":{
        "descriptions":[
          ". Panel B: Immunostaining of SSc-MVECs with anti-desmoglein-2 and anti-integrin-beta8 antibodies (nuclei stained with DAPI) after transient transfection with control vector (upper pictures) or DSG2 transfection (lower pictures). The results shown are indicative of experiments performed on 3 SSc-MVEC cell lines. Original magnification: X60 (Bio-Rad MRC 1024 ES Confocal Laser Scanning Microscope)"
        ],
        "rois":[
          {
            "x":19,
            "y":641,
            "x2":1502,
            "y2":1037
          }
        ]
      },
      "C":{
        "descriptions":[
          ". Panel C: Capillary morphogenesis in control and DSG2-transfected SSc-MVECs. Pictures show the results of a typical experiment out of 3 experiments performed in triplicate in each one of the different SSc-MVEC lines (SSc-MVEC 1, 2 and 3)."
        ],
        "rois":[
          {
            "x":17,
            "y":1063,
            "x2":1500,
            "y2":2035
          }
        ]
      }
    }
  },
  "748172":{
    
  },
  "751860":{
    "Figure_5.tif":{
      "A":{
        "descriptions":[
          "(A), PcrAsFH "
        ],
        "rois":[
          {
            "x":22,
            "y":22,
            "x2":5831,
            "y2":2018
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B), PcrAMpn "
        ],
        "rois":[
          {
            "x":22,
            "y":22,
            "x2":5831,
            "y2":2018
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) or PcrAMge "
        ],
        "rois":[
          {
            "x":30,
            "y":2165,
            "x2":2859,
            "y2":4146
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D). The protein concentrations tested were 0 pM, 50 pM, 0.2 nM, 0.8 nM, 3.2 nM, 12.5 nM, 25 nM, 50 nM and 100 nM. DNA unwinding was quantified by determination of the percentage of free (labeled) oligonucleotide that was displaced from the DNA substrates. Quantification was performed using Quantity One software (Bio-Rad), after separation of reaction products on polyacrylamide gels. Data shown are the average of two independent experiments. Error bars indicate the standard deviation of the mean. In the inset at the right-hand corner of each graph, a detail is shown of the DNA helicase activity (%) at the lowest protein concentrations tested."
        ],
        "rois":[
          {
            "x":3005,
            "y":2166,
            "x2":5831,
            "y2":4146
          }
        ]
      }
    }
  },
  "752542":{
    "Figure_1.tif":{
      "R":{
        "descriptions":[
          "R. heilongjiangensis biotinylated proteins isolated by biotin-streptavidin affinity purification were separated using a pH 3???10 NL IPG strip (Bio-Rad, Richmond"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2027,
            "y2":2056
          }
        ]
      },
      "CA":{
        "descriptions":[
          ", CA) in the first dimension followed by 12% SDS-PAGE. Numbers with arrowheads refer to the protein spots in the silver-stained gel. Protein spots excised from the gel were digested and subjected to ESI-MS/MS analysis. The relative molecular masses of the marker proteins are indicated in kDa on the left side of the figure and the protein spots identified by ESI-MS/MS analysis are listed in Table S2."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "755046":{
    "Figure_9.tif":{
      "A":{
        "descriptions":[
          "Panel A: Production of CC-chemokines by PBMC and the effects of adefovir, tenofovir, and PMEO-DAPym on the expression of the CCR5 receptor. Freshly isolated PBMCs from four healthy donors were incubated for 24 h with medium only "
        ],
        "rois":[
          {
            "x":343,
            "y":15,
            "x2":3453,
            "y2":2886
          }
        ]
      },
      "NC":{
        "descriptions":[
          "(NC) or with adefovir, tenofovir, or PMEO-DAPym. We collected the supernatants and measured the concentrations of MIP-1?? (???), MIP-1?? (???), and RANTES (???) using a Bioplex system (Bio-Rad, Hercules"
        ],
        "rois":[
          
        ]
      },
      "CA":{
        "descriptions":[
          ", CA). Shown are means ?? SEM. The cells were also collected, and the expression of the CCR5 receptor (???) was measured with flow cytometry using the PE-labeled CCR5 (clone 2D7) mAb; it is shown as percentage of control (?? SEM) from four independent representative experiments"
        ],
        "rois":[
          {
            "x":651,
            "y":2816,
            "x2":2965,
            "y2":5013
          }
        ]
      },
      "B":{
        "descriptions":[
          ". Panel B: Chemokine mRNA expression upon PMEO-DAPym exposure to PBMC. RT-PCR analysis of MIP-1??, MIP-1??, RANTES, and GAPDH (control) expression in PBMC treated with 100-??g/ml PMEO-DAPym for 4 h. Similar results were obtained with PBMC from three different donors. Results from one representative donor are shown."
        ],
        "rois":[
          {
            "x":343,
            "y":15,
            "x2":3453,
            "y2":2886
          }
        ]
      }
    }
  },
  "756407":{
    
  },
  "756412":{
    
  },
  "757003":{
    
  },
  "759300":{
    "Figure_6.tif":{
      "LN":{
        "descriptions":[
          "(LN) and obese "
        ],
        "rois":[
          {
            "x":9,
            "y":8,
            "x2":2044,
            "y2":928
          }
        ]
      },
      "OB":{
        "descriptions":[
          "(OB) were treated with Thbs1 inhibitor LSKL, or with Arg1 inhibitor ABH ammonium salt, immediately before the exposure to P. gingivalis (P.g). After 4 h incubation, cytokines in the cell culture supernatants were measured by Bio-Plex cytokine array. The data presented are means of 3 replicates. *PP"
        ],
        "rois":[
          {
            "x":9,
            "y":8,
            "x2":2044,
            "y2":928
          }
        ]
      }
    }
  },
  "759350":{
    
  },
  "760012":{
    
  },
  "760898":{
    "Figure_1.tif":{
      "A":{
        "descriptions":[
          "(A). The short variant (Pol?? ?? Ex 8) presents a 103 bp deletion corresponding to exon 8. This deletion removes one part of the active site of the protein. The BRCT (breast cancer suppressor protein carboxy-terminal) and the Pol X domain, which contains the active site, are required for Pol?? function. Pol?? variants were amplified using primers indicated by horizontal arrows "
        ],
        "rois":[
          {
            "x":11,
            "y":9,
            "x2":1852,
            "y2":2521
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B). Quantification of the obtained PCR products using a Gel Doc 2000 and the Quantity One v.4.3.1 software (Bio-Rad, Hercules, CA, USA) indicates that the short isoform represents 16% and 6% of the Pol?? transcripts in the spleen and testis of P. waltl, respectively. Ctl??????=???negative control. MW???=???100 bp DNA ladder. A cladogram was then constructed by neighbor joining "
        ],
        "rois":[
          {
            "x":11,
            "y":9,
            "x2":1852,
            "y2":2521
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) supported with 1000 bootstrap replications using the MEGA4 software (http://www.megasoftware.net/) and the following sequences: Terminal deoxynucleotidyl transferase (TdT); Bos taurus (DAA14763), Homo sapiens (BAB72001), Mus musculus (NP_001036693), Gallus gallus (NP_990720), Ambystoma mexicanum (AA092254), Xenopus laevis (NP_001079251), Danio rerio (AAS89780). Polymerase beta; Mus musculus (NP_035260), Homo sapiens (NP_002681), Xenopus laevis (NP_001081643), Xenopus tropicalis (AAH74537), Xiphophorus maculatus (AAU11319). Polymerase lambda; Danio rerio (NP_998408), Xenopus tropicalis (NP_001093716), Mus musculus (NP_064416), Homo sapiens (NP_001167555). Polymerase mu; Homo sapiens (NP_037416), Mus musculus (NP_059097), Danio rerio (NP_956542), Xenopus tropicalis (NP_001164987), Pleurodeles waltl (HE583591). The scale bar corresponds to the evolutionary distance."
        ],
        "rois":[
          {
            "x":11,
            "y":9,
            "x2":1852,
            "y2":2521
          }
        ]
      }
    }
  },
  "763778":{
    
  },
  "763779":{
    "Figure_2.tif":{
      "E":{
        "descriptions":[
          ". E. bEnd5 cells co-cultured with astrocytes (+AC) in comparison to bEnd5 cell monocultures (???AC)."
        ],
        "rois":[
          {
            "x":1113,
            "y":1646,
            "x2":2109,
            "y2":2365
          }
        ]
      },
      "A":{
        "descriptions":[
          ". A. Representative TEER/Ccl measurement comparing MBMECs, bEnd5 and bEnd5 infected with LEF??N-??CTA (??CTA-bEnd5), indicating that ??-catenin transcriptional activation leads to increased electrical resistance in bEnd5 cells. Vertical line at 125 hours indicates media exchange and boxed insert shows magnification of the Ccl curves after the media exchange, highlighting pronounced lower values for the ??CTA-bEnd5 compared to bEnd5 controls"
        ],
        "rois":[
          {
            "x":14,
            "y":14,
            "x2":2696,
            "y2":1593
          },
          {
            "x":2814,
            "y":17,
            "x2":3852,
            "y2":727
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B. Parental bEnd5 cells in comparison to the primary mouse MBMECs cells (n???=???3)"
        ],
        "rois":[
          {
            "x":1152,
            "y":2502,
            "x2":2069,
            "y2":3268
          },
          {
            "x":72,
            "y":2480,
            "x2":995,
            "y2":3268
          },
          {
            "x":2814,
            "y":17,
            "x2":3852,
            "y2":727
          },
          {
            "x":1729,
            "y":14,
            "x2":2745,
            "y2":730
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C. bEnd5 cells infected with lenti-LEF??N-??CTA in comparison to the lenti-GFP control"
        ],
        "rois":[
          {
            "x":1152,
            "y":2502,
            "x2":2069,
            "y2":3268
          },
          {
            "x":2814,
            "y":17,
            "x2":3852,
            "y2":727
          },
          {
            "x":2881,
            "y":815,
            "x2":3781,
            "y2":1592
          }
        ]
      },
      "D":{
        "descriptions":[
          ". D. bEnd5 cells treated with the GSK3??/?? inhibitor 6-BIO (2.5 ??M) in comparison to the DMSO-treated cells"
        ],
        "rois":[
          {
            "x":17,
            "y":1646,
            "x2":1046,
            "y2":2372
          }
        ]
      }
    }
  },
  "765028":{
    
  },
  "770544":{
    "Figure_3.tif":{
      "A":{
        "descriptions":[
          "A) SDS-PAGE analysis: Lane 1: Rhodococcus T104 pHPNV culture broth; lane 2???1 ??g protein after octyl FF sepharose purification step; lane 3???0.89 ??g of purified protein after phenyl HP sepharose purification step; lane 4: Bio-Rad broad range molecular weight standards. Bands corresponding to PhaZSa are marked with an arrow"
        ],
        "rois":[
          {
            "x":11,
            "y":11,
            "x2":2038,
            "y2":578
          }
        ]
      },
      "B":{
        "descriptions":[
          ". B) Spot test activity assay: Rhodococcus T104 pNV19 culture broth (negative control), Rhodococcus T104 pHPNV culture broth, pooled fractions after octyl FF sepharose purification step and pooled fractions after phenyl HP sepharose."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "774835":{
    "Figure_6.tif":{
      "A":{
        "descriptions":[
          "(A). The relative intensity of the HA bands compared to each of the control (PBS i.n. and s.c.) samples was obtained using Image Lab version 3.0 (BIO RAD) "
        ],
        "rois":[
          {
            "x":16,
            "y":16,
            "x2":1999,
            "y2":1233
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B). Experiments were performed 3 times, and averages and standard deviations are shown. Student t-test was used for statistical analysis."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "774903":{
    "Figure_1.tif":{
      "E":{
        "descriptions":[
          "(E) rectal tissue."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":506,
            "y2":532
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) modified balance; "
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          "(B) weights; "
        ],
        "rois":[
          {
            "x":507,
            "y":0,
            "x2":987,
            "y2":532
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) metal plate; "
        ],
        "rois":[
          {
            "x":507,
            "y":0,
            "x2":987,
            "y2":532
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) in situ gelling enema; "
        ],
        "rois":[
          {
            "x":507,
            "y":0,
            "x2":987,
            "y2":532
          }
        ]
      }
    }
  },
  "774909":{
    
  },
  "777378":{
    "Figure_1.tif":{
      "PC":{
        "descriptions":[
          "(PC) and negative control "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3917,
            "y2":2909
          }
        ]
      },
      "NC":{
        "descriptions":[
          "(NC) were included in each plate during phage ELISA. The strongest positive clones were selected for subsequent cloning and expression as monomer and multimer (combody) in E.coli."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":3917,
            "y2":2909
          }
        ]
      }
    }
  },
  "777443":{
    
  },
  "780234":{
    "Figure_1.tif":{
      "A":{
        "descriptions":[
          "(A) PRC1 complexes catalyze monoubiquitylation of histone H2A lysine 119 (H2AK119ub1). The catalytic subunits are RING1A/B and one of six PCGF protein homologues, PCGF1???6. PRC1 exists in canonical and noncanonical forms. Canonical PRC1 complexes comprise RING1A/B, PCGF2/4, the CBX protein subunit that has a chromodomain "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1359,
            "y2":2207
          }
        ]
      },
      "CD":{
        "descriptions":[
          "(CD) that binds specifically to PRC2-mediated H3K27me3, and the PH subunit. In noncanonical PRC1, CBX proteins are substituted by the RYBP/YAF2 subunit and the PH subunit is absent. Association of additional subunits with noncanonical PRC1 occurs in a manner dependent on the associated PCGF protein. Thus, PCGF1 complexes, discussed extensively herein, include the additional subunits BCOR and KDM2B. KDM2B has a zinc finger CxxC domain (CXXC) that mediates binding to unmethylated CpG dinucleotides. PRC2 complexes methylate histone H3 lysine 27 (H3K27me1/2/3) and comprise the catalytic EZH2 protein and the core subunits EED, SUZ12, and RBAP48. JARID2 is a substoichiometric subunit that has been implicated in PRC2 targeting. "
        ],
        "rois":[
          
        ]
      },
      "B":{
        "descriptions":[
          "(B) PcG complexes occupy CpG islands at target gene promoters: an example from genome-wide ChIP-seq analysis of mouse embryonic stem cells illustrating a PcG target gene, Lhx4. The Bio-CAP procedure provides a molecular readout of the density of unmethylated CpG dinucleotides with peaks corresponding to CpG islands. ChIP-seq for PRC1 (RING1B) and PRC2 (EZH2) subunits illustrates that PcG protein occupancy closely mirrors unmethylated CpG density."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1359,
            "y2":2207
          }
        ]
      }
    }
  },
  "781821":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "A) Serum levels of pro-inflammatory cytokines were increased in ApcMin/+ mice after H. hepaticus infection. Eotaxin, IL-3, TNF-?? and IL-1?? were significantly elevated in comparison with age-matched uninfected ApcMin/+ controls. When compared with H. hepaticus infected wt mice, infected ApcMin/+ mice had significantly higher IL-17, IL-1??, IL-3, eotaxin and IL-9 concentration in their blood serum. Bio-Plex Cytokine Assay used sera of n=5 mice per group. ***pB) Paracortical areas in mesenteric lymph nodes"
        ],
        "rois":[
          {
            "x":38,
            "y":46,
            "x2":2009,
            "y2":1049
          }
        ]
      },
      "H":{
        "descriptions":[
          ". H. hepaticus infected ApcMin/+ mice at high risk of prostate cancer had large amounts of cytoplasmic and extracellular IL-17 that significantly decreased after depletion of TNF-??"
        ],
        "rois":[
          {
            "x":32,
            "y":1078,
            "x2":2010,
            "y2":1968
          },
          {
            "x":38,
            "y":46,
            "x2":2009,
            "y2":1049
          }
        ]
      },
      "C":{
        "descriptions":[
          ". C) Morphometric assessment of IL-17 in immunohistochemically stained sections of mesenteric lymph nodes. Both ApcMin/+ genetic status and intestinal infection by H. hepaticus significantly correlate with a TNF-??-mediated increase of IL-17 expression in the mesenteric lymph nodes. ***p"
        ],
        "rois":[
          {
            "x":38,
            "y":46,
            "x2":2009,
            "y2":1049
          }
        ]
      }
    }
  },
  "78267":{
    
  },
  "78268":{
    
  },
  "78269":{
    
  },
  "78270":{
    
  },
  "783075":{
    
  },
  "783097":{
    "Figure_6.tif":{
      "A":{
        "descriptions":[
          "(A) MCF-7, Cd7 and Cd12 cells were harvested for chromatin immunoprecititation (ChIP) analysis. ChIP analysis was done with ??-ER??, ??-c-fos, ??-c-jun, and ??-Sp1, and recruitment of proteins to the SDF-1, cyclin D1 and c-myc promoters was determined using promoter specific primers and semi-quantitative PCR. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2151,
            "y2":214
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Band intensities of PCR products for SDF-1, cycD, and c-myc were quantified and normalized to input using Quantity One (Bio-Rad) "
        ],
        "rois":[
          {
            "x":0,
            "y":215,
            "x2":2151,
            "y2":435
          },
          {
            "x":0,
            "y":436,
            "x2":267,
            "y2":675
          }
        ]
      },
      "PC":{
        "descriptions":[
          "(PC) In the ChIP re-ChIP assay, DNA/protein complexes from the first ChIP assay were extracted and re-ChIPed with a second antibody. The occupancy of ER??/c-jun or c-Jun/ER?? complexes on the SDF-1 promoter was analyzed as in B "
        ],
        "rois":[
          {
            "x":0,
            "y":436,
            "x2":267,
            "y2":675
          },
          {
            "x":0,
            "y":676,
            "x2":2151,
            "y2":2033
          },
          {
            "x":268,
            "y":436,
            "x2":2151,
            "y2":675
          }
        ]
      },
      "PD":{
        "descriptions":[
          "(PD) To confirm the presence of c-fos in the ER??/c-jun complex, reChIPed DNA containing ER??/c-jun complexes were immunoprecipitated with a third antibody, ??-c-fos, and the resulting DNA fragments were analyzed as in B (P"
        ],
        "rois":[
          
        ]
      }
    }
  },
  "783295":{
    "Figure_3.tif":{
      "1":{
        "descriptions":[
          ": 1. rLaSota"
        ],
        "rois":[
          {
            "x":11,
            "y":423,
            "x2":969,
            "y2":1267
          },
          {
            "x":9,
            "y":9,
            "x2":955,
            "y2":368
          }
        ]
      },
      "2":{
        "descriptions":[
          ", 2. rBan/AF"
        ],
        "rois":[
          {
            "x":9,
            "y":9,
            "x2":955,
            "y2":368
          }
        ]
      },
      "3":{
        "descriptions":[
          ", 3. rLaSota-Ban/AF F"
        ],
        "rois":[
          {
            "x":9,
            "y":9,
            "x2":955,
            "y2":368
          }
        ]
      },
      "4":{
        "descriptions":[
          ", 4. rLaSota-Ban/AF HN, and 5. rLaSota-Ban/AF F HN (B) The relative levels of the F0 and F1 proteins in the Western blot experiment in part C were measured by Bio-Rad Gel Image analysis, and the efficiency of cleavage was determined by dividing the amount of F1 by the amount of F1 plus F0. Each bar represents mean and standard error of the mean of triplicate samples."
        ],
        "rois":[
          {
            "x":9,
            "y":9,
            "x2":955,
            "y2":368
          }
        ]
      }
    }
  },
  "78438":{
    
  },
  "78439":{
    "Emi0010-0978-f5.jpg":{
      "A":{
        "descriptions":[
          "(A) Xyn-RC(LNA-Even); or "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":799,
            "y2":325
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Xyn-RC(LNA-5???)] was used in the RCA reaction. Products were analysed with an Agilent 2100 Bioanalyser with a DNA 7500 LabChip?? kit (TaKaRa-Bio).Copyright information:Taken from \"Retrieval of entire genes from environmental DNA by inverse PCR with pre-amplification of target genes using primers containing locked nucleic acids\"Environmental Microbiology 2008;10(4):978-987.Published online 01 Apr 2008PMCID:PMC2327201.?? 2007 The Authors Journal compilation ?? 2007 Society for Applied Microbiology and Blackwell Publishing Ltd"
        ],
        "rois":[
          {
            "x":0,
            "y":326,
            "x2":799,
            "y2":882
          }
        ]
      }
    }
  },
  "784678":{
    
  },
  "787007":{
    "Figure_1.tif":{
      "E":{
        "descriptions":[
          "(E) High levels of CD147 expression in hypopharyngeal squamous cell carcinoma: diffuse cytoplasmic staining. "
        ],
        "rois":[
          {
            "x":855,
            "y":1371,
            "x2":1685,
            "y2":2035
          },
          {
            "x":9,
            "y":9,
            "x2":838,
            "y2":673
          }
        ]
      },
      "F":{
        "descriptions":[
          "(F) Low level of CD147 expression in epithelium adjacent to carcinoma."
        ],
        "rois":[
          {
            "x":855,
            "y":9,
            "x2":1685,
            "y2":673
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) High levels of COX-2 expression in hypopharyngeal squamous cell carcinoma: diffuse cytoplasmic staining. "
        ],
        "rois":[
          {
            "x":9,
            "y":1371,
            "x2":838,
            "y2":2035
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Low levels of COX-2 expression in epithelium adjacent to carcinoma. "
        ],
        "rois":[
          {
            "x":855,
            "y":1371,
            "x2":1685,
            "y2":2035
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) High levels of CD44v6 expression in hypopharyngeal squamous cell carcinoma: cell membrane staining. "
        ],
        "rois":[
          {
            "x":855,
            "y":1371,
            "x2":1685,
            "y2":2035
          },
          {
            "x":9,
            "y":691,
            "x2":1684,
            "y2":1355
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D) High levels of CD44v6 expression in epithelium adjacent to carcinoma as well as staining in carcinoma tissues. "
        ],
        "rois":[
          {
            "x":855,
            "y":1371,
            "x2":1685,
            "y2":2035
          },
          {
            "x":9,
            "y":691,
            "x2":1684,
            "y2":1355
          }
        ]
      }
    }
  },
  "787012":{
    "Figure_2.tif":{
      "T":{
        "descriptions":[
          "(T) High levels of CD147 expression in tumor tissue with lymph node metastasis. "
        ],
        "rois":[
          {
            "x":718,
            "y":7,
            "x2":1404,
            "y2":556
          }
        ]
      },
      "U":{
        "descriptions":[
          "(U) Low levels of CD147 expression in tumor tissue without lymph node metastasis."
        ],
        "rois":[
          {
            "x":718,
            "y":567,
            "x2":1404,
            "y2":1117
          }
        ]
      },
      "Q":{
        "descriptions":[
          "(Q) Low levels of COX-2 expression in tumor tissue without lymph node metastasis. "
        ],
        "rois":[
          {
            "x":7,
            "y":1138,
            "x2":694,
            "y2":1688
          },
          {
            "x":717,
            "y":1137,
            "x2":1404,
            "y2":1687
          },
          {
            "x":718,
            "y":7,
            "x2":1404,
            "y2":556
          }
        ]
      },
      "P":{
        "descriptions":[
          "(P) High levels of COX-2 expression in tumor tissue with lymph node metastasis. "
        ],
        "rois":[
          {
            "x":717,
            "y":1137,
            "x2":1404,
            "y2":1687
          },
          {
            "x":7,
            "y":7,
            "x2":694,
            "y2":1118
          }
        ]
      },
      "R":{
        "descriptions":[
          "(R) High levels of CD44v6 expression in tumor tissue with lymph node metastasis. "
        ],
        "rois":[
          {
            "x":7,
            "y":1138,
            "x2":694,
            "y2":1688
          },
          {
            "x":717,
            "y":1137,
            "x2":1404,
            "y2":1687
          },
          {
            "x":718,
            "y":7,
            "x2":1404,
            "y2":556
          }
        ]
      },
      "S":{
        "descriptions":[
          "(S) Low levels of CD44v6 expression in tumor tissue without lymph node metastasis. "
        ],
        "rois":[
          {
            "x":717,
            "y":1137,
            "x2":1404,
            "y2":1687
          },
          {
            "x":718,
            "y":7,
            "x2":1404,
            "y2":556
          }
        ]
      }
    }
  },
  "787019":{
    "Figure_3.tif":{
      "N":{
        "descriptions":[
          "(N) CD147 expression in moderate differentiated tumor tissues. "
        ],
        "rois":[
          {
            "x":1365,
            "y":7,
            "x2":1998,
            "y2":513
          }
        ]
      },
      "J":{
        "descriptions":[
          "(J) CD44v6 expression in well differentiated tumor tissues. "
        ],
        "rois":[
          {
            "x":692,
            "y":1096,
            "x2":1325,
            "y2":1605
          },
          {
            "x":692,
            "y":7,
            "x2":1325,
            "y2":513
          }
        ]
      },
      "M":{
        "descriptions":[
          "(M) CD147 expression in well differentiated tumor tissues. "
        ],
        "rois":[
          {
            "x":692,
            "y":7,
            "x2":1325,
            "y2":513
          },
          {
            "x":691,
            "y":547,
            "x2":1325,
            "y2":1056
          }
        ]
      },
      "I":{
        "descriptions":[
          "(I) COX-2 expression in poorly differentiated tumor tissues. "
        ],
        "rois":[
          {
            "x":1365,
            "y":1096,
            "x2":1998,
            "y2":1605
          },
          {
            "x":692,
            "y":7,
            "x2":1325,
            "y2":513
          }
        ]
      },
      "G":{
        "descriptions":[
          "(G) COX-2 expression in well differentiated tumor tissues. "
        ],
        "rois":[
          {
            "x":7,
            "y":547,
            "x2":640,
            "y2":1056
          }
        ]
      },
      "L":{
        "descriptions":[
          "(L) CD44v6 expression in poorly differentiated tumor tissues. "
        ],
        "rois":[
          {
            "x":692,
            "y":7,
            "x2":1325,
            "y2":513
          },
          {
            "x":1367,
            "y":547,
            "x2":2002,
            "y2":1056
          }
        ]
      },
      "H":{
        "descriptions":[
          "(H) COX-2 expression in moderate differentiated tumor tissues. "
        ],
        "rois":[
          {
            "x":7,
            "y":7,
            "x2":640,
            "y2":515
          }
        ]
      },
      "K":{
        "descriptions":[
          "(K) CD44v6 expression in moderate differentiated tumor tissues. "
        ],
        "rois":[
          {
            "x":692,
            "y":7,
            "x2":1325,
            "y2":513
          },
          {
            "x":7,
            "y":547,
            "x2":640,
            "y2":1056
          }
        ]
      },
      "O":{
        "descriptions":[
          "(O) CD147 expression in poorly differentiated tumor tissues."
        ],
        "rois":[
          {
            "x":7,
            "y":1096,
            "x2":640,
            "y2":1605
          }
        ]
      }
    }
  },
  "787111":{
    "Figure_3.tif":{
      "E":{
        "descriptions":[
          "(E,G) BIO. Asterisks: dental lamina, White arrows: tooth germs; yellow arrowhead: successional lamina. "
        ],
        "rois":[
          {
            "x":500,
            "y":868,
            "x2":971,
            "y2":1338
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          },
          {
            "x":603,
            "y":1914,
            "x2":1129,
            "y2":2470
          }
        ]
      },
      "N":{
        "descriptions":[
          "(N) LiCl treatment. "
        ],
        "rois":[
          {
            "x":1100,
            "y":7,
            "x2":2037,
            "y2":342
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          }
        ]
      },
      "J":{
        "descriptions":[
          "(J) percentage of the number of tooth germs in 3-day snake cultures after treatment, n???=???number of slices analyzed. "
        ],
        "rois":[
          {
            "x":1100,
            "y":7,
            "x2":2037,
            "y2":342
          },
          {
            "x":500,
            "y":868,
            "x2":971,
            "y2":1338
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          }
        ]
      },
      "F":{
        "descriptions":[
          "(D,F) LiCl, "
        ],
        "rois":[
          {
            "x":500,
            "y":868,
            "x2":971,
            "y2":1338
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          },
          {
            "x":8,
            "y":1340,
            "x2":971,
            "y2":1810
          }
        ]
      },
      "A":{
        "descriptions":[
          "(A) RT-PCR analysis of Axin2 and Lunatic fringe (Lnfg) mRNA levels of the dental organ indicating Axin2 and Lnfg are up-regulated after LiCl treatment. EF1?? was used as a loading control. (B???G) F-Actin detection after 3 days of culture in "
        ],
        "rois":[
          {
            "x":8,
            "y":9,
            "x2":971,
            "y2":867
          }
        ]
      },
      "M":{
        "descriptions":[
          "(M) control, "
        ],
        "rois":[
          {
            "x":1127,
            "y":894,
            "x2":2054,
            "y2":1354
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          }
        ]
      },
      "I":{
        "descriptions":[
          "(I) Number of new tooth germs that appeared during 3 days of treatment and "
        ],
        "rois":[
          {
            "x":500,
            "y":868,
            "x2":971,
            "y2":1338
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          },
          {
            "x":603,
            "y":1914,
            "x2":1129,
            "y2":2470
          }
        ]
      },
      "G":{
        "descriptions":[
          "(E,G) BIO. Asterisks: dental lamina, White arrows: tooth germs; yellow arrowhead: successional lamina. "
        ],
        "rois":[
          {
            "x":500,
            "y":868,
            "x2":971,
            "y2":1338
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          },
          {
            "x":8,
            "y":1340,
            "x2":971,
            "y2":1810
          }
        ]
      },
      "Q":{
        "descriptions":[
          "(P,Q) BIO treatment. White arrows: tooth germs and epithelial projections. Yellow arrow: dysmorphic tooth germ. White asterisks: dental lamina. Yellow asterisks: acanthosis in dental lamina. Scale bars: 100 ??m."
        ],
        "rois":[
          
        ]
      },
      "L":{
        "descriptions":[
          "(K,L) Morphology of dental organs after 7 days of control culture ",
          "(L). Asterisks: dental lamina, Black arrows: tooth germs. (M???Q) Histology of explanted dental organs after 10 days in culture: "
        ],
        "rois":[
          {
            "x":500,
            "y":868,
            "x2":971,
            "y2":1338
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          },
          {
            "x":1592,
            "y":1974,
            "x2":2054,
            "y2":2432
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Control, "
        ],
        "rois":[
          {
            "x":8,
            "y":9,
            "x2":971,
            "y2":867
          }
        ]
      },
      "P":{
        "descriptions":[
          "(P,Q) BIO treatment. White arrows: tooth germs and epithelial projections. Yellow arrow: dysmorphic tooth germ. White asterisks: dental lamina. Yellow asterisks: acanthosis in dental lamina. Scale bars: 100 ??m."
        ],
        "rois":[
          {
            "x":8,
            "y":1340,
            "x2":971,
            "y2":1810
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) DMSO and "
        ],
        "rois":[
          {
            "x":8,
            "y":9,
            "x2":971,
            "y2":867
          }
        ]
      },
      "H":{
        "descriptions":[
          "(H) The volume of the dental organ does not change after GSK3?? inhibitor treatment. "
        ],
        "rois":[
          {
            "x":500,
            "y":868,
            "x2":971,
            "y2":1338
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          },
          {
            "x":29,
            "y":1907,
            "x2":518,
            "y2":2468
          }
        ]
      },
      "K":{
        "descriptions":[
          "(K,L) Morphology of dental organs after 7 days of control culture ",
          "(K) and LiCl culture "
        ],
        "rois":[
          {
            "x":500,
            "y":868,
            "x2":971,
            "y2":1338
          },
          {
            "x":1128,
            "y":394,
            "x2":2057,
            "y2":864
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          }
        ]
      },
      "O":{
        "descriptions":[
          "(O) DMSO control and "
        ],
        "rois":[
          {
            "x":29,
            "y":1907,
            "x2":518,
            "y2":2468
          }
        ]
      },
      "D":{
        "descriptions":[
          "(D,F) LiCl, "
        ],
        "rois":[
          {
            "x":8,
            "y":868,
            "x2":478,
            "y2":1338
          },
          {
            "x":1127,
            "y":1356,
            "x2":2054,
            "y2":1971
          }
        ]
      }
    }
  },
  "787119":{
    "Figure_5.tif":{
      "E":{
        "descriptions":[
          "(E, F) Quantification of the samples represented in A???D showing ",
          "(E) increase of pH3+ cells and "
        ],
        "rois":[
          {
            "x":1358,
            "y":30,
            "x2":1985,
            "y2":666
          },
          {
            "x":216,
            "y":1424,
            "x2":1337,
            "y2":2295
          },
          {
            "x":7,
            "y":7,
            "x2":1283,
            "y2":1377
          }
        ]
      },
      "F":{
        "descriptions":[
          "(E, F) Quantification of the samples represented in A???D showing ",
          "(F) increase in mitotic index after LiCl and BIO treatment, n???=???number of slices analyzed. "
        ],
        "rois":[
          {
            "x":1359,
            "y":728,
            "x2":1985,
            "y2":1401
          }
        ]
      },
      "G":{
        "descriptions":[
          "(G) Distribution of the number of pH3+ cells along the different regions of the dental organ represented in the scheme. Significant differences were found in the dental lamina after LiCl and BIO treatment. Scale bar: 100 ??m."
        ],
        "rois":[
          {
            "x":1393,
            "y":1661,
            "x2":1862,
            "y2":2119
          },
          {
            "x":216,
            "y":1424,
            "x2":1337,
            "y2":2295
          }
        ]
      }
    }
  },
  "788388":{
    "Figure_S1.tif":{
      "Z":{
        "descriptions":[
          ". Z. bailii grew at acetic acid concentrations above 24 g L???1, while limited growth of S. cerevisiae was observed after 11 h when cultured with only 12 g L???1 acetic acid. Detailed lipidomic profiling using electrospray ionization, multiple-reaction-monitoring mass spectrometry (ESI-MRM-MS) showed remarkable changes in the glycerophospholipid composition of Z. bailii, including an increase in saturated glycerophospholipids and considerable increases in complex sphingolipids in both S. cerevisiae (IPC 6.2??, MIPC 9.1??, M"
        ],
        "rois":[
          {
            "x":64,
            "y":26,
            "x2":2692,
            "y2":1523
          }
        ]
      },
      "IP":{
        "descriptions":[
          "(IP)2C 2.2??) and Z. bailii (IPC 4.9??, MIPC 2.7??, M",
          "(IP)2C 2.7??), when cultured with acetic acid. In addition, the basal level of complex sphingolipids was significantly higher in Z. bailii than in S. cerevisiae, further emphasizing the proposed link between lipid saturation, high sphingolipid levels and acetic acid tolerance. The results also suggest that acetic acid tolerance is associated with the ability of a given strain to generate large rearrangements in its lipid profile."
        ],
        "rois":[
          
        ]
      }
    },
    "Figure_S2.tif":{
      "Z":{
        "descriptions":[
          ". Z. bailii grew at acetic acid concentrations above 24 g L???1, while limited growth of S. cerevisiae was observed after 11 h when cultured with only 12 g L???1 acetic acid. Detailed lipidomic profiling using electrospray ionization, multiple-reaction-monitoring mass spectrometry (ESI-MRM-MS) showed remarkable changes in the glycerophospholipid composition of Z. bailii, including an increase in saturated glycerophospholipids and considerable increases in complex sphingolipids in both S. cerevisiae (IPC 6.2??, MIPC 9.1??, M"
        ],
        "rois":[
          {
            "x":39,
            "y":17,
            "x2":2684,
            "y2":1512
          }
        ]
      },
      "IP":{
        "descriptions":[
          "(IP)2C 2.2??) and Z. bailii (IPC 4.9??, MIPC 2.7??, M",
          "(IP)2C 2.7??), when cultured with acetic acid. In addition, the basal level of complex sphingolipids was significantly higher in Z. bailii than in S. cerevisiae, further emphasizing the proposed link between lipid saturation, high sphingolipid levels and acetic acid tolerance. The results also suggest that acetic acid tolerance is associated with the ability of a given strain to generate large rearrangements in its lipid profile."
        ],
        "rois":[
          
        ]
      }
    },
    "Figure_S3.tif":{
      "Z":{
        "descriptions":[
          ". Z. bailii grew at acetic acid concentrations above 24 g L???1, while limited growth of S. cerevisiae was observed after 11 h when cultured with only 12 g L???1 acetic acid. Detailed lipidomic profiling using electrospray ionization, multiple-reaction-monitoring mass spectrometry (ESI-MRM-MS) showed remarkable changes in the glycerophospholipid composition of Z. bailii, including an increase in saturated glycerophospholipids and considerable increases in complex sphingolipids in both S. cerevisiae (IPC 6.2??, MIPC 9.1??, M"
        ],
        "rois":[
          {
            "x":89,
            "y":26,
            "x2":2666,
            "y2":1521
          }
        ]
      },
      "IP":{
        "descriptions":[
          "(IP)2C 2.2??) and Z. bailii (IPC 4.9??, MIPC 2.7??, M",
          "(IP)2C 2.7??), when cultured with acetic acid. In addition, the basal level of complex sphingolipids was significantly higher in Z. bailii than in S. cerevisiae, further emphasizing the proposed link between lipid saturation, high sphingolipid levels and acetic acid tolerance. The results also suggest that acetic acid tolerance is associated with the ability of a given strain to generate large rearrangements in its lipid profile."
        ],
        "rois":[
          
        ]
      }
    },
    "Figure_S4.tif":{
      "Z":{
        "descriptions":[
          ". Z. bailii grew at acetic acid concentrations above 24 g L???1, while limited growth of S. cerevisiae was observed after 11 h when cultured with only 12 g L???1 acetic acid. Detailed lipidomic profiling using electrospray ionization, multiple-reaction-monitoring mass spectrometry (ESI-MRM-MS) showed remarkable changes in the glycerophospholipid composition of Z. bailii, including an increase in saturated glycerophospholipids and considerable increases in complex sphingolipids in both S. cerevisiae (IPC 6.2??, MIPC 9.1??, M"
        ],
        "rois":[
          {
            "x":78,
            "y":25,
            "x2":2652,
            "y2":1510
          }
        ]
      },
      "IP":{
        "descriptions":[
          "(IP)2C 2.2??) and Z. bailii (IPC 4.9??, MIPC 2.7??, M",
          "(IP)2C 2.7??), when cultured with acetic acid. In addition, the basal level of complex sphingolipids was significantly higher in Z. bailii than in S. cerevisiae, further emphasizing the proposed link between lipid saturation, high sphingolipid levels and acetic acid tolerance. The results also suggest that acetic acid tolerance is associated with the ability of a given strain to generate large rearrangements in its lipid profile."
        ],
        "rois":[
          
        ]
      }
    },
    "Figure_S5.tif":{
      "Z":{
        "descriptions":[
          ". Z. bailii grew at acetic acid concentrations above 24 g L???1, while limited growth of S. cerevisiae was observed after 11 h when cultured with only 12 g L???1 acetic acid. Detailed lipidomic profiling using electrospray ionization, multiple-reaction-monitoring mass spectrometry (ESI-MRM-MS) showed remarkable changes in the glycerophospholipid composition of Z. bailii, including an increase in saturated glycerophospholipids and considerable increases in complex sphingolipids in both S. cerevisiae (IPC 6.2??, MIPC 9.1??, M"
        ],
        "rois":[
          {
            "x":32,
            "y":32,
            "x2":2728,
            "y2":1507
          }
        ]
      },
      "IP":{
        "descriptions":[
          "(IP)2C 2.2??) and Z. bailii (IPC 4.9??, MIPC 2.7??, M",
          "(IP)2C 2.7??), when cultured with acetic acid. In addition, the basal level of complex sphingolipids was significantly higher in Z. bailii than in S. cerevisiae, further emphasizing the proposed link between lipid saturation, high sphingolipid levels and acetic acid tolerance. The results also suggest that acetic acid tolerance is associated with the ability of a given strain to generate large rearrangements in its lipid profile."
        ],
        "rois":[
          
        ]
      }
    },
    "Figure_S6.tif":{
      "Z":{
        "descriptions":[
          ". Z. bailii grew at acetic acid concentrations above 24 g L???1, while limited growth of S. cerevisiae was observed after 11 h when cultured with only 12 g L???1 acetic acid. Detailed lipidomic profiling using electrospray ionization, multiple-reaction-monitoring mass spectrometry (ESI-MRM-MS) showed remarkable changes in the glycerophospholipid composition of Z. bailii, including an increase in saturated glycerophospholipids and considerable increases in complex sphingolipids in both S. cerevisiae (IPC 6.2??, MIPC 9.1??, M"
        ],
        "rois":[
          {
            "x":16,
            "y":27,
            "x2":2737,
            "y2":1503
          }
        ]
      },
      "IP":{
        "descriptions":[
          "(IP)2C 2.2??) and Z. bailii (IPC 4.9??, MIPC 2.7??, M",
          "(IP)2C 2.7??), when cultured with acetic acid. In addition, the basal level of complex sphingolipids was significantly higher in Z. bailii than in S. cerevisiae, further emphasizing the proposed link between lipid saturation, high sphingolipid levels and acetic acid tolerance. The results also suggest that acetic acid tolerance is associated with the ability of a given strain to generate large rearrangements in its lipid profile."
        ],
        "rois":[
          
        ]
      }
    }
  },
  "789807":{
    "Figure_2.tif":{
      "A":{
        "descriptions":[
          "M14 cell line (104 cells) was cultured and lysed with the Trizol reagent, in-house and Bio-Rad cell-to-Ct reagents. After reverse transcription, the cDNA samples were amplified by RPS8, ZNF706, RNF167, hsa-miR-29a, hsa-miR-197, hsa-miR-297 PCR assays. Graph bars represent (A)"
        ],
        "rois":[
          {
            "x":11,
            "y":11,
            "x2":2212,
            "y2":904
          }
        ]
      },
      "B":{
        "descriptions":[
          " CVs and (B)"
        ],
        "rois":[
          {
            "x":76,
            "y":991,
            "x2":2255,
            "y2":1923
          }
        ]
      }
    }
  },
  "789809":{
    "Figure_3.tif":{
      "A":{
        "descriptions":[
          "(A) in-house or "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1166,
            "y2":1321
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Bio-Rad lysis buffer. The cDNA samples generated from cell lysates were amplified by PCR assays from set 2. Standard curves for isolated RNAs were plotted as Ct versus Log (cells per RT). The experiments were conducted with biological duplicates."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1166,
            "y2":1321
          },
          {
            "x":1167,
            "y":0,
            "x2":2136,
            "y2":1321
          }
        ]
      }
    }
  },
  "789812":{
    "Figure_4.tif":{
      "A":{
        "descriptions":[
          "(A) in-house or "
        ],
        "rois":[
          {
            "x":11,
            "y":11,
            "x2":1114,
            "y2":780
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Bio-Rad lysis buffers and incubated at room temperature across various durations (5, 10, 30, 60, 120, 240 min). The cDNA samples generated from cell lysates were amplified by PCR assays from set 2. Ct was plotted against duration of incubation to examine the stability of RNA in room temperature. The experiments were conducted with biological duplicates."
        ],
        "rois":[
          {
            "x":18,
            "y":11,
            "x2":2255,
            "y2":1457
          }
        ]
      }
    }
  },
  "789813":{
    "Figure_5.tif":{
      "A":{
        "descriptions":[
          "(A) in-house or "
        ],
        "rois":[
          {
            "x":12,
            "y":12,
            "x2":1157,
            "y2":766
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Bio-Rad lysis buffers. Cell lysates were collected and aliquoted. The lysates were then frozen at ???70??C, thawed in a temperature-controlled water bath at 25??C, and the freeze-thaw cycles repeated. The miRNA and mRNA expressions were quantified following 1, 3, 5, 10 freeze-thaw cycles. The qPCR assays from set 2 were used for quantifications. Ct was plotted against freeze-thaw cycles to examine the stability of RNA. The experiments were conducted in biological duplicates."
        ],
        "rois":[
          {
            "x":18,
            "y":12,
            "x2":2330,
            "y2":1473
          }
        ]
      }
    }
  },
  "790551":{
    "Figure_9.tif":{
      "A":{
        "descriptions":[
          "(A) SDS-PAGE gel for C. neoformans recombinant (His)6-Bwc2. Left to right, lane 1 is the low molecular weight Bio-Rad protein ladder, lane 2, 3, 4 are purified recombinant Bwc2 eluted fractions. Lane 5 is crude unpurified protein extract. "
        ],
        "rois":[
          {
            "x":19,
            "y":14,
            "x2":1014,
            "y2":694
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) Gel mobility shift assay for a fragment of the JEC21 UVE1 promoter with purified Bwc2. Left to right, lane 1 contains just the UVE1 promoter P1 (PUVE1), lane 2, 3 and 4 contains P1+Bwc2 20 ??g, 50 ??g and 20 ??g+Zn2+ respectively. Lane 5 is loaded with the non-specific radiolabeled probe P2. Lane 6, 7 are P1+Bwc2 20 ??g and 50 ??g. Lane 8, 9 are competition with the increasing amount of specific probe cold P1 to negate any binding observed in lane 7. Lane 10 is Bwc2 and P2 with Zn2+."
        ],
        "rois":[
          {
            "x":15,
            "y":792,
            "x2":1120,
            "y2":1962
          }
        ]
      }
    }
  },
  "791323":{
    
  },
  "791451":{
    "Figure_3.tif":{
      "a":{
        "descriptions":[
          "(a) The dimer structure of subunits A (red) and B (green) shows no disulfide bond formation between the Cys61 residues of the two monomers (Insets). Density maps superimposed with atomic models of two helices from the boxed region, showing no density that can be attributed to disulfide bond formation between the two interacting monomers in this region. The density maps are contoured at 4.5?? (left inset) and 3?? (right inset) above the mean. "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2048,
            "y2":2242
          }
        ]
      },
      "b":{
        "descriptions":[
          "(b) The dimer structure of subunits C (yellow) and B (blue) also show no disulfide bond formation between the Cys61 residues of the two monomers based on the cryoEM density map (Bottom insets). Density maps superimposed with atomic models of two helices from the boxed region, showing no density that can be attributed to disulfide bond formation between the two interacting monomers in this region. The density maps are contoured at 4.5?? (left inset) and 3?? (right inset) above the mean. "
        ],
        "rois":[
          
        ]
      },
      "c":{
        "descriptions":[
          "(c) SDS-PAGE analysis of freshly-purified HBV core reveal no disulfide bond formation between core subunits. Lane 1: molecular-weight standards from Bio-Rad. Lane 2: HBV core boiled for 5 minutes under non-reducing condition; no dimer band was observed. Lane 3: HBV core boiled for 5 minutes under reducing condition with 5% (v/v) ??-mercaptoethanol. A 10??g protein sample per lane was loaded and visualized by Coomassie Blue staining."
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":2048,
            "y2":2242
          }
        ]
      }
    }
  },
  "793880":{
    "Figure_4.tif":{
      "A":{
        "descriptions":[
          "(A) Flow cytometry analysis of intracellular IL-12p40 in MGL2+ dDCs, MGL2???CD103??? skin-derived DCs, and CD103+ dDCs in skin-draining LNs under na??ve or sensitized conditions. MGL2+ dDCs are shown as ???MGL2,??? MGL2???CD103??? DCs are shown as ???DN??? and CD103+ dDCs are shown as ???CD103.??? Cells from na??ve mice are shown as ???Na??ve,??? and cells from sensitized mice are shown as ???Sensitized.??? Areas shaded in gray indicate the staining pattern with an isotype control antibody. The numbers represent the mean fluorescence intensity (MFI) of each skin-derived DC subset. "
        ],
        "rois":[
          {
            "x":8,
            "y":7,
            "x2":970,
            "y2":642
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) The MFI of IL-12p40 for each skin-derived DC subset is shown in panel A in bar graphs. Data are shown as the mean ?? SD of three biological replicates (n???=???3); n.s. indicates that the difference is not statistically significant. (A???B) The experiments were independently performed three times. "
        ],
        "rois":[
          {
            "x":11,
            "y":679,
            "x2":913,
            "y2":1150
          }
        ]
      },
      "C":{
        "descriptions":[
          "(C) Concentrations of IL-12p40 and IL-12p70 in culture supernatant of MHCIIhighMGL2+ dDCs, MHCIIhighCD103+ dDCs, FITC+MGL2+ dDCs, and FITC+CD103+ dDCs were measured by the Bio-Plex Suspension Array System and are shown in the panels as ???Naive MGL2,??? ???Na??ve CD103,??? ???Sensitized MGL2,??? and ???Sensitized CD103,??? respectively. The experiments were independently performed two times."
        ],
        "rois":[
          {
            "x":9,
            "y":1160,
            "x2":913,
            "y2":1688
          }
        ]
      }
    }
  },
  "79616":{
    
  },
  "79617":{
    
  },
  "79618":{
    
  },
  "79619":{
    
  },
  "79621":{
    
  },
  "79622":{
    
  },
  "79623":{
    
  },
  "79624":{
    
  },
  "79625":{
    
  },
  "79626":{
    
  },
  "79627":{
    
  },
  "79653":{
    
  },
  "79654":{
    
  },
  "79655":{
    
  },
  "79656":{
    
  },
  "796603":{
    "Figure_11.tif":{
      "A":{
        "descriptions":[
          "(A) or subcutaneous "
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1144,
            "y2":2254
          }
        ]
      },
      "B":{
        "descriptions":[
          "(B) adipose tissue were obtained from Zen-Bio and differentiated as per their instructions for 14 days. A subset of cells were left untreated (control"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1144,
            "y2":2254
          }
        ]
      },
      "C":{
        "descriptions":[
          ", C) or were incubated in media supplemented with macrophage conditioned media (MCM, 5% v/v) or with 100 ng/ml of Tumor necrosis factor alpha (TNF??), Total RNA was isolated and FIP1 and adiponectin mRNA was quantitated by real time PCR as indicated in the methods section. Relative quantification was carried out using the ??????Ct method using PPIA gene expression as an internal control. Statistical analysis: One way ANOVA. * indicates statistical significance pC) Fully differentiated 3T3L1 adipocytes were incubated in the absence (control",
          ", C) or presence of TNF?? (TNF??) or Interleukin 6 (IL6) at 50 ng/ml for 24 hours, Total RNA was isolated and the amount of mRNA for FIP1, or Glut4 was determined by real time PCR. Quantification was carried out using the ??????Ct method using cyclophyllin A as internal control. The graph shows data from a representative experiment of two independent experiments each carried out with triplicate cell dishes for each group. Statistical analysis: One way ANOVA, ** indicates p"
        ],
        "rois":[
          {
            "x":0,
            "y":0,
            "x2":1144,
            "y2":2254
          }
        ]
      }
    }
  }
}
